At its meeting on March 18 & 19, 2024, the PCORI Board of Governors received an Executive Director's update and engaged in several strategy discussions, including ones that relate to PCORnet® and PCORI's National Priorities for Health, as well as PCORI's work to build an evidence base for the implementation of comparative clinical effectiveness research into practice, among other business. View the agenda for additional information.

Meeting Materials

Webinar Recordings

Public Comment Period

This meeting included a public comment period on Tuesday, March 19. Registration^ was required to provide comments via telephone. (Guidelines for Public Comments) (Technical Guidance for Commenters). However, as there were no confirmed requests to provide comments by 5 pm (ET) on the business day before the scheduled public comment period, the public comment period was not initiated.

All PCORI Board meetings are open to the public. Members of the public could tune in to this meeting, which took place over two days, via teleconference/webinar. Registration was required. Members of the Board convened at the PCORI offices in Washington, DC, for this meeting. Catch up on past PCORI Board meetings here.

*The agenda was subject to change. The meeting adjourned ahead of schedule at 2:25 pm (ET) on March 19.

^Please note that after you sign up to provide comment at this meeting, you will receive a confirmation email from PCORI about your registration. Please check your spam folder for this email if you don’t receive it, and read the information carefully to confirm your intention to provide comment.


Location Type